tiprankstipranks
Trending News
More News >
BioNTech SE (BNTX)
NASDAQ:BNTX
US Market

BioNTech SE (BNTX) Income Statement

Compare
4,749 Followers

BioNTech SE Income Statement

Last quarter (Q3 2025), BioNTech SE's total revenue was €1.52B, an increase of 22.02% from the same quarter last year. In Q3, BioNTech SE's net income was €-28.70M. See BioNTech SE’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 2.75B€ 3.82B€ 17.31B€ 18.98B€ 482.30M
Gross Profit
€ 2.21B€ 3.22B€ 14.32B€ 16.07B€ 423.00M
Operating Expenses
€ 3.52B€ 2.53B€ 1.67B€ 781.40M€ 505.40M
Depreciation and Amortization
€ 298.00M€ 183.40M€ 123.30M€ 75.20M€ 38.70M
EBITDA
€ -367.10M€ 1.38B€ 13.10B€ 15.00B€ -105.10M
Operating Income
€ -1.31B€ 690.40M€ 12.64B€ 15.28B€ -82.40M
Other Income/Expenses
€ 636.60M€ 495.70M€ 311.40M€ -237.40M€ -63.40M
Pretax Income
€ -677.70M€ 1.19B€ 12.95B€ 15.05B€ -145.80M
Net Income
€ -665.30M€ 930.30M€ 9.43B€ 10.29B€ 15.20M
Per Share Metrics
Basic EPS
€ -2.77€ 3.87€ 38.08€ 43.87€ 0.06
Diluted EPS
€ -2.77€ 3.83€ 37.09€ 41.21€ 0.06
Weighted Average Shares Outstanding
240.40M 240.60M 243.30M 244.00M 235.44M
Weighted Average Shares Outstanding (Diluted)
240.40M 242.70M 249.80M 259.70M 248.53M
Currency in EUR

BioNTech SE Earnings and Revenue History